Novel mouse model of left ventricular pressure overload and infarction causing predictable ventricular remodelling and progression to heart failure. (January 2015)
- Record Type:
- Journal Article
- Title:
- Novel mouse model of left ventricular pressure overload and infarction causing predictable ventricular remodelling and progression to heart failure. (January 2015)
- Main Title:
- Novel mouse model of left ventricular pressure overload and infarction causing predictable ventricular remodelling and progression to heart failure
- Authors:
- Weinheimer, Carla J
Lai, Ling
Kelly, Daniel P
Kovacs, Attila - Abstract:
- <abstract abstract-type="main" id="cep12318-abs-0001"> <title>Summary</title> <p>Mouse surgical models are important tools for evaluating mechanisms of human cardiac disease. The clinically relevant comorbidities of hypertension and ischaemia have not been explored in mice. We have developed a surgical approach that combines transverse aortic constriction and distal left anterior coronary ligation (MI) to produce a gradual and predictable progression of adverse left ventricular (LV) remodelling that leads to heart failure (HF). Mice received either sham, MI alone, transverse aortic constriction alone or HF surgery. Infarct size and LV remodelling were evaluated by serial 2‐D echocardiograms. Transverse aortic constriction gradients were measured by the Doppler velocity–time integral ratio between constricted and proximal aortic velocities. At 4 weeks, hearts were weighed and analysed for histology and brain natriuretic peptide, a molecular marker of HF. Echocardiographic analysis of segmental wall motion scores showed similarly small apical infarct sizes in the MI and HF groups at day 1 postsurgery. MI alone showed little change in infarct size over 4 weeks (0.26 ± 0.02 to 0.27 ± 0.04, <italic>P</italic> = 0.77); however, HF mice showed infarct expansion (0.25 ± 0.06 to 0.39 ± 0.09, <italic>P</italic> &lt; 0.05). HF mice also showed LV remodelling with increases in LV volumes (1 day = 36.5 ± 5.2 mL, 28 days = 89.1 ± 16.0 mL) versus no significant changes in the other groups.<abstract abstract-type="main" id="cep12318-abs-0001"> <title>Summary</title> <p>Mouse surgical models are important tools for evaluating mechanisms of human cardiac disease. The clinically relevant comorbidities of hypertension and ischaemia have not been explored in mice. We have developed a surgical approach that combines transverse aortic constriction and distal left anterior coronary ligation (MI) to produce a gradual and predictable progression of adverse left ventricular (LV) remodelling that leads to heart failure (HF). Mice received either sham, MI alone, transverse aortic constriction alone or HF surgery. Infarct size and LV remodelling were evaluated by serial 2‐D echocardiograms. Transverse aortic constriction gradients were measured by the Doppler velocity–time integral ratio between constricted and proximal aortic velocities. At 4 weeks, hearts were weighed and analysed for histology and brain natriuretic peptide, a molecular marker of HF. Echocardiographic analysis of segmental wall motion scores showed similarly small apical infarct sizes in the MI and HF groups at day 1 postsurgery. MI alone showed little change in infarct size over 4 weeks (0.26 ± 0.02 to 0.27 ± 0.04, <italic>P</italic> = 0.77); however, HF mice showed infarct expansion (0.25 ± 0.06 to 0.39 ± 0.09, <italic>P</italic> &lt; 0.05). HF mice also showed LV remodelling with increases in LV volumes (1 day = 36.5 ± 5.2 mL, 28 days = 89.1 ± 16.0 mL) versus no significant changes in the other groups. Furthermore, systolic function progressively deteriorated in the HF group only (ejection fraction, 1 day = 55.6 ± 3.6%, 28 days = 17.6 ± 4.1%, <italic>P</italic> &lt; 0.05) with an increase of brain natriuretic peptide by 3.5‐fold. This surgical model of pressure overload in the setting of a small infarction causes progressive deterioration of cardiac structural and functional properties, and provides a clinically relevant tool to study adverse LV remodelling and heart failure.</p> </abstract> … (more)
- Is Part Of:
- Clinical and experimental pharmacology and physiology. Volume 42:Number 1(2015:Jan.)
- Journal:
- Clinical and experimental pharmacology and physiology
- Issue:
- Volume 42:Number 1(2015:Jan.)
- Issue Display:
- Volume 42, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 42
- Issue:
- 1
- Issue Sort Value:
- 2015-0042-0001-0000
- Page Start:
- 33
- Page End:
- 40
- Publication Date:
- 2015-01
- Subjects:
- Clinical pharmacology -- Periodicals
Pharmacology, Experimental -- Periodicals
Physiology, Experimental -- Periodicals
Physiology, Pathological -- Periodicals
615.1 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=cep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1440-1681.12318 ↗
- Languages:
- English
- ISSNs:
- 0305-1870
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.252000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3872.xml